Ben Gilbert: belief

Transcript context

…That's showing great promise. It was approved in the U S for Diabetes treatment in May, 2022. Approval just came recently in November, 2023 for official FDA sanctioned weight loss use case under the marketing name Zepbound. Look for that in 2024. What this really shows though between Eli Lilly, Novo, and other companies that are almost certainly going to get into the GLP-1 business, I think this is going to be like Insulin all over again, where there's just going to be a series of product improvements, and companies will drive innovation and increase supply. The demand is so huge out there that Mounjaro can be a huge hit. Ozempic and Wegovy will continue to be huge hits. Other companies getting into the game will be huge hits. Novo has next generation GLP-1 drugs in the pipeline themselves. CagriSema is the big one that they're currently working on, that they think will be as good, if not better than what Eli Lilly has with Tirzepatide. I think we're basically just assuming that everything continues to be proven safe in the long run, we're kicking off a new super cycle here in pharma development around these compounds, just like played out with Insulin over the last century. Yup. It really also just goes to show like it was time. Multiple researchers arrived at similar ideas concurrently, which we see over and over again in the world. Uber and Lyft is our modern canonical example. Cellular connectivity plus GPS, plus iPhone made it possible to do something for the first time. Multiple parties were arriving at the same time to do that. I think science had just arrived at a place, where multiple parties could develop similar things side by side. Now, there's certainly a catch up race among other pharmaceutical companies who weren't doing this to now try to get into it and see if they can compete. Totally.…

Stored transcript either side of the excerpt. The highlighted words are the published quote; the surrounding text is unedited source, never generated.